Subcutaneous Adipose 11β-Hydroxysteroid Dehydrogenase Type 1 Activity and Messenger Ribonucleic Acid Levels Are Associated with Adiposity and Insulinemia in Pima Indians and Caucasians
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Metabolic effects of cortisol may be critically modulated by glucocorticoid metabolism in tissues. Specifically, active cortisol is regenerated from inactive cortisone by the enzyme 11 beta-hydroxysteroid dehydrogenase type 1 (11-HSD1) in adipose and liver. We examined activity and mRNA levels of 11-HSD1 and tissue cortisol and cortisone levels in sc adipose tissue biopsies from 12 Caucasian (7 males and 5 females) and 19 Pima Indian (10 males and 9 females) nondiabetic subjects aged 28 +/- 7.6 yr (mean +/- SD; range, 18-45). Adipose 11-HSD1 activity and mRNA levels were highly correlated (r = 0.51, P = 0.003). Adipose 11-HSD1 activity was positively related to measures of total (body mass index, percentage body fat) and central (waist circumference) adiposity (P < 0.05 for all) and fasting glucose (r = 0.43, P = 0.02), insulin (r = 0.60, P = 0.0005), and insulin resistance by the homeostasis model (r = 0.70, P < 0.0001) but did not differ between sexes or ethnic groups. Intra-adipose cortisol was positively associated with fasting insulin (r = 0.37, P = 0.04) but was not significantly correlated with 11-HSD1 mRNA or activity or with other metabolic variables. In this cross-sectional study, higher adipose 11-HSD1 activity is associated with features of the metabolic syndrome. Our data support the hypothesis that increased regeneration of cortisol in adipose tissue influences metabolic sequelae of human obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This differential effect was largely related to the impact on β-cell function11,138.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [138]
In the citing paper
“Whereas the onset of glucose lowering with the other two medications was slower, it was most sustained with rosiglitazone, with metformin demonstrating an intermediate pattern.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [138]
In the citing paper
“Glibenclamide produced the greatest initial reduction in glycaemia, but was poorest in maintaining glucose control.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [138]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
Rosmond, R., Dallman, M. F., & Björntorp, P. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4843 · Cited by 871
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
The role of TNFα and TNF receptors in obesity and insulin resistance
Hotamisligil, G. S. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00490.x · Cited by 780 · cited 1×
“46 Fasting insulin (mU/liter) 45 [38–52] 38 [32–51] 0.”
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753
Seckl, J. R., & Walker, B. R. (2001) · Endocrinology · doi:10.1210/endo.142.4.8114 · Cited by 714
Self-citationTissue-Specific Dysregulation of Cortisol Metabolism in Human Obesity
Rask, E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1418 · Cited by 655
Self-citationPhillips, D. I. W., Barker, D. J. P., Fall, C. H. D., Seckl, J. R., Whorwood, C. B., Wood, P. J., & Walker, B. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4634 · Cited by 596
Rosmond, R. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.1853 · Cited by 590
Research works printed but not linked: 1
- 1985, Diabetes mellitus
Cited by
Items 201–224 of 224
Cortisol Metabolism as a Regulator of the Tissue-Specific Glucocorticoid Action
Sbardella, E., & Tomlinson, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_14 · Cited by 3
El síndrome metabólico como síndrome de Cushing intrahepatocitario
Vázquez, G. F., Torrecilla, E., & Rubio, M. Á. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.12.003 · Cited by 2
Salivary Cortisol Can Reflect Adiposity and Insulin Sensitivity in Type 2 Diabetes
Matsuzawa, Y., Sakurai, K., Saito, J., Omura, M., & Nishikaw, T. (2011) · InTech eBooks · doi:10.5772/27172 · Cited by 1
“It was also reported that the expression of 11β-HSD1 is increased in adipose tissue in simple obesity (Rask et al.,2002, Paulmyer-Lacroi et al.,2002, Lindsay et al.,2003), suggesting that the ratio of F to E is a biomarker for assessing the adiposity in obese patients.”
BackgroundTakaya, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-31143-2_61-1 · Cited by 1
11β-Hydroxysteroid Dehydrogenase Type 1 and Obesity
Stimson, R. H., & Walker, B. R. (2007) · Humana Press eBooks · doi:10.1007/978-1-60327-139-4_10 · Cited by 1
Self-citationKobayashi, N., Masuzaki, H., Tanaka, T., Yasue, S., Ishii, T., Tomita, T., Miyawaki, T., Komeda, T., Fukuda, Y., Kusakabe, T., et al. (2009) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2008.11.002 · Cited by 1
Estrogen and Glucocorticoid Metabolism
Andersson, T. (2010) · DiVA at Umeå University (Umeå University)
Michailidou, Z. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
11β‐Hydroxysteroid Dehydrogenase Type 1 as a Therapeutic Target for Type 2 Diabetes
Hale, C., & Jean, D. J. S. (2011) · Wiley eBooks · doi:10.1002/9780470910016.ch16
11β-Hydroxysteroid Dehydrogenase Type 1 is not Overexpressed in Cushing’s Syndrome Adipose Depots
Kater, C. E. (2014) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2014.01.00006
Chronic food restriction up-regulates 11-β-hydroxysteroid dehydrogenase
Śledziński, T., Turyn, J., Stelmańska, E., Presler, M., Klimek, J., & Świerczyński, J. (2011) · Open Life Sciences · doi:10.2478/s11535-011-0014-z
Tomlinson, J. (2009) · Clinical Lipidology · doi:10.2217/clp.09.31
Interactions between glucocorticoid metabolism and inflammation in obesity and insulin resistance.
Nixon, M. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Stachoń, M., Fürstenberg, E., Siriska, B., Gadzialska, J., & Gromadzka-Ostrowska, J. (2006) · Polish Journal of Food and Nutrition Sciences
Bos, P. (2010) · Nottingham ePrints (University of Nottingham)
The metabolic syndrome as intrahepatocytic Cushing's syndrome
Vázquez, G. F., Torrecilla, E., & Rubio, M. Á. (2011) · Endocrinología y Nutrición (English Edition) · doi:10.1016/s2173-5093(11)70039-3
Short Communication Portal and peripheral cortisol levels in obese humans
Aldhahi, W., Mun, E., & Goldfine, A. B. (2004)
Glucocorticoids as Modulators of Adipose Inflammation
Morton, N. M. (2009) · Oxidative stress and disease · doi:10.1201/9781420091311.ch8
Alterations in peripheral glucocorticoid metabolism : effects of weight changes
Šimonytė, K. (2011) · DiVA at Umeå University (Umeå University)
Paulsen, S. K., Nielsen, M. P., Richelsen, B., Bruun, J. M., Flyvbjerg, A., & Pedersen, S. B. (2008) · Obesity · doi:10.1038/oby.2007.141
Takaya, J. (2019) · Springer eBooks · doi:10.1007/978-3-319-55530-0_61
Metadata
- Authors
- Lindsay, R. S., Wake, D. J., Nair, S., Bunt, J., Livingstone, D. E. W., Permana, P. A., Tataranni, P. A., & Walker, B. R.
- Affiliations
- National Institutes of Health (US)
- Western General Hospital (GB)
- Corresponding author
- Tataranni, P. Antonio
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06-01
- Volume
- 88
- Issue
- 6
- Pages
- 2738-2744
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1978718098
- Cited by
- 225
- References
- 42
- Citations by year
- 2024: 2 · 2023: 1 · 2021: 6 · 2020: 1 · 2019: 5 · 2018: 3 · 2017: 5 · 2016: 4 · 2015: 9 · 2014: 10 · 2013: 9 · 2012: 10
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, subcutaneous adipose tissue, cortisol, cortisone, adiposity, insulin levels, insulin resistance, metabolic syndrome, obesity, Pima Indians, ethnic differences, gene expression, fasting blood glucose
- MeSH terms
- Adipose Tissue, Adult, Cortisone, Female, Humans, Hydroxysteroid Dehydrogenases, Indians, North American, Insulin, Male, Obesity, RNA, Messenger, Subcutaneous Tissue, 11-beta-Hydroxysteroid Dehydrogenase Type 1, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.